Rabih Hage, Claire Alapetite, Hervé Brisse, Kevin Zuber, Augustin Lecler, Guillaume Lot, Caroline Le Guerinel, Catherine Vignal-Clermont, Herve Boissonnet
PURPOSE: Management of optic nerve sheath meningiomas (ONSM) remains challenging. Photon radiation therapy (PhRT) is the most common treatment for sight-threatening ONSM. Proton beam therapy (PBT) is less commonly used because it is more expensive and because there are questions about its efficacy specifically in relation to ONSM. PBT has the theoretical advantage of reducing radiation exposure to adjacent structures. We report the visual outcome of patients with primary ONSM managed at the Fondation Ophtalmologique Adolphe de Rothschild, Paris, France, and treated with PBT at the Centre de Protonthérapie, Institut Curie, Orsay, France...
2021: Eye and Brain